Full Text View
Tabular View
No Study Results Posted
Related Studies
Rapid Antidepressant Effects of Ketamine in Major Depression
This study is currently recruiting participants.
Verified November 2012 by National Institutes of Health Clinical Center (CC)
Study NCT00088699   Information provided by National Institutes of Health Clinical Center (CC)

First Received on July 30, 2004.   Last Updated on December 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
Major Depression/Bipolar Disorder
Additional conditions recognized in this trial
Bipolar Disorder
Depressive Disorder
Depressive Disorder, Major
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
Ketamine
Riluzole
FDG
Additional drug interventions recognized in this trial
Antidepressive Agents
More general drug interventions related to this trial
Analgesics
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Anticonvulsants
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services